BioCentriq Menu
  • About
    • Close
    • Team
  • Services
    • Close
    • Clinical Manufacturing
    • Process Development
    • Workforce Development
  • Therapies
    • Close
    • Cell Therapy
    • Gene Therapy
  • Events
  • News
  • Careers
  • Contact Us
  • Search
Home In the News

In the News

  • Biopharma
BioProcess Inte...
Wednesday, June 29, 2022

CGT industry needs skilled staff to fuel further growth says McKinsey

McKinsey & Comp...
2 weeks ago

New McKinsey center helps clients build capabilities in cell and gene therapy technology

Outsourced Phar...
4 weeks ago

We Need More University-Based CDMOs

Patch
4 weeks ago

New Jersey Innovation Institute Sells BioCentriq For $73M

GlobeNewswire
4 weeks ago

New Jersey Innovation Institute Announces Sale of its Subsidiary, BioCentriq, for $73 Million

Pharma Manufact...
5 months ago

BioCentriq expands cell and gene therapy manufacturing facilities

ROI NJ
5 months ago

BioCentriq completes construction of 9,000 sq. ft. manufacturing facility in South Brunswick

BioSpace
5 months ago

Three Life Sciences Players Up Their Footprint with Manufacturing Expansions

NJ Business Mag...
5 months ago

BioCentriq Completes New Clinical Manufacturing Facility

Outsourced Phar...
5 months ago

BioCentriq Expands Its Clinical Manufacturing Facilities For Cell & Gene Therapies

Labiotech
8 months ago

Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing

BioProcess Inte...
8 months ago

Terumo and BioCentriq to drive automated CGT manufacturing

    • About
    • Careers
    • Events
    • News
    • Team
    • Clinical Manufacturing
    • Process Development
    • Workforce Development
    • Gene Therapy
    • Cell Therapy
    • Contact

© BIOCENTRIQ 2021. ALL RIGHTS RESERVED. | PRIVACY POLICY | TERMS OF USE